rs10499161 |
chr6 |
129912799 |
0.00000401 |
A |
G |
Change in depression severity with antidepressants (NRI or SRI) |
ARHGAP18 |
intron |
23091423
|
rs10499162 |
chr6 |
129919010 |
0.0007 |
T |
C |
Colorectal cancer |
ARHGAP18 |
intron |
17618283
|
rs9321174 |
chr6 |
129921216 |
0.000024 |
G |
A |
Cognitive function |
ARHGAP18 |
intron |
24684796
|
rs4604290 |
chr6 |
129923552 |
0.000034 |
A |
C |
Cognitive function |
ARHGAP18 |
intron |
24684796
|
rs12530181 |
chr6 |
129925003 |
0.00000326 |
A |
G |
Cognitive impairment induced by topiramate |
ARHGAP18 |
intron |
22091778
|
rs9375641 |
chr6 |
129948198 |
0.000748 |
T |
C |
Smoking initiation |
ARHGAP18 |
intron |
24665060
|
rs9375645 |
chr6 |
129955117 |
0.00095 |
A |
C |
Myopia (pathological) |
ARHGAP18 |
intron |
21095009
|
rs4310078 |
chr6 |
129957731 |
0.000147 |
T |
C |
Alzheimer's disease |
ARHGAP18 |
intron |
pha002879
|
rs6931247 |
chr6 |
129961976 |
0.000368 |
G |
A |
Multiple complex diseases |
ARHGAP18 |
intron |
17554300
|
rs4479964 |
chr6 |
129971544 |
0.0000444 |
G |
A |
Multiple complex diseases |
ARHGAP18 |
intron |
17554300
|
rs4479964 |
chr6 |
129971544 |
0.000707 |
G |
A |
Myopia (pathological) |
ARHGAP18 |
intron |
21095009
|
rs9388721 |
chr6 |
129971929 |
0.00018 |
C |
T |
Type 2 diabetes |
ARHGAP18 |
intron |
17463246
|
rs12197901 |
chr6 |
129973843 |
0.000138 |
T |
C |
HIV-1 viral setpoint |
ARHGAP18 |
intron |
17641165
|
rs9402156 |
chr6 |
129973962 |
0.000883 |
A |
T |
Alzheimer's disease |
ARHGAP18 |
intron |
17998437
|
rs17811901 |
chr6 |
129979762 |
0.000144 |
C |
T |
Type 2 diabetes |
ARHGAP18 |
intron |
17463246
|
rs6569617 |
chr6 |
129980436 |
0.0002 |
T |
C |
Prostate cancer |
ARHGAP18 |
intron |
23555315
|
rs13209334 |
chr6 |
129982914 |
0.00068 |
C |
A |
Myopia (pathological) |
ARHGAP18 |
intron |
21095009
|
rs6922711 |
chr6 |
129986792 |
0.000887 |
T |
C |
Myopia (pathological) |
ARHGAP18 |
intron |
21095009
|
rs6920979 |
chr6 |
130005667 |
0.0000085 |
G |
T |
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) |
ARHGAP18 |
intron |
23648065
|
rs12660691 |
chr6 |
130008445 |
0.000004 |
A |
C |
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) |
ARHGAP18 |
intron |
23648065
|
rs1894642 |
chr6 |
130015331 |
0.0000455 |
T |
G |
Smoking cessation |
ARHGAP18 |
intron |
18519826
|
rs1894642 |
chr6 |
130015331 |
0.000275335 |
T |
G |
Hypertension (early onset hypertension) |
ARHGAP18 |
intron |
22479346
|
rs17057640 |
chr6 |
130019354 |
0.000005 |
T |
C |
Cognitive function |
ARHGAP18 |
intron |
24684796
|
rs763132 |
chr6 |
130020347 |
0.000119 |
A |
C |
Smoking cessation |
ARHGAP18 |
intron |
18519826
|
rs2157460 |
chr6 |
130021128 |
0.00000707 |
A |
G |
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) |
ARHGAP18 |
intron |
23648065
|
rs12529067 |
chr6 |
130023213 |
0.0001 |
A |
G |
Cognitive impairment induced by topiramate |
ARHGAP18 |
intron |
22091778
|
rs2068685 |
chr6 |
130029839 |
0.0000089 |
G |
A |
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) |
ARHGAP18 |
intron |
23648065
|